Table of Contents

A patent infringement analysis Leeds companies commission is prepared in one city and litigated in another. Your R&D, your accused competitor and your commercial evidence sit in West Yorkshire; the two courts that will decide whether a patent is infringed sit almost 200 miles south, in the Rolls Building on Fetter Lane in London. Between the two is a body of work that decides whether you should be in a courtroom at all: a rigorous mapping of the claims onto the accused product, a candid view of validity, and an honest estimate of what winning is worth against what it costs. Getting that analysis right in Leeds is what stops a strong instinct becoming a weak case.
Why a patent infringement analysis Leeds businesses rely on points south to London
Start with the geography, because it decides everything that follows. The UK Intellectual Property Office, which grants and administers UK patents, sits at Concept House, Cardiff Road, Newport, in South Wales. It examines and grants rights; it does not hear infringement disputes. When a Leeds patentee wants to enforce, or a Leeds business is accused of infringing, the venue is a court, not the registry, and there are only two of them in England and Wales.
Both are in London. The Patents Court is part of the Business and Property Courts within the Chancery Division of the High Court, and the Intellectual Property Enterprise Court, the IPEC, sits alongside it. Both are housed in the Rolls Building, and both draw on a small pool of specialist judges who read patents for a living. A patent infringement analysis Leeds in-house teams and their solicitors rely on is written, in practice, to be understood by that London bench.
That distance is not a disadvantage, but it changes how the analysis is used. A West Yorkshire company cannot walk a judge round its factory floor. Everything the court sees, it sees on paper first: the claim chart, the construction argument, the expert’s view of the common general knowledge. The analysis is the case, months before anyone stands up to open it.
The two courts that will read your infringement analysis
The first choice in any UK patent matter is which of the two courts to be in, and it turns almost entirely on value and complexity. The Patents Court hears the larger, more technically demanding disputes, and its damages and recoverable costs are uncapped. It is where pharmaceutical, telecoms and standards-essential patent fights are decided, and where the losing side can face a costs bill running well into seven figures.
The IPEC is the proportionate forum for smaller and less complex claims, and it is deliberately built for SMEs of exactly the kind Leeds produces. Damages in the IPEC multi-track are capped at ยฃ500,000 per claim, recoverable costs at ยฃ60,000 for the liability stage and ยฃ30,000 for the quantum stage since the October 2022 uplift. Trials are limited to two days, disclosure is tightly controlled, and the cost exposure is knowable in advance.
Choosing between them is a strategic decision, not an administrative one, and it should be made on the numbers the analysis produces. If the infringing sales are modest and the technology is not fiendishly complex, the IPEC’s cost cap can make a claim viable that would be reckless in the Patents Court. If the right is valuable and the defendant well resourced, the cap becomes a ceiling on recovery you may not want. We size the dispute before we recommend a court.
What the Business and Property Courts in Leeds can and cannot hear
Leeds does have its own Business and Property Courts. The Leeds District Registry sits on the North Eastern Circuit and is one of the regional centres, alongside Manchester, Birmingham, Bristol, Cardiff, Liverpool and Newcastle, where High Court Chancery and commercial business is heard outside London. For most business litigation, a Leeds company can and should litigate in Leeds.
Patents are the exception, and this catches people out. Since 31 October 2019 the IPEC small claims track can be issued and heard in the Leeds Business and Property Courts, which is a genuine regional gain for copyright, unregistered design and trade mark disputes. But patent and registered-design claims are expressly excluded from the small claims track. A patent infringement claim cannot be run there.
The practical consequence is blunt. Whatever the Leeds District Registry can offer, a patent infringement action still has to be issued in the Patents Court or the IPEC multi-track in London. So the analysis is not written for a local judge who might visit the site; it is written for the Rolls Building. Knowing that at the outset shapes the evidence you gather in Leeds, because it will have to travel and stand on its own.
The Shorter Trials Scheme: a mid-tier route with a ยฃ500,000 costs cap
Between the uncapped Patents Court and the capped IPEC sits a route that has changed the arithmetic for mid-sized Leeds businesses, and it is often overlooked. From 1 January 2024 a pilot cost-capping scheme applies to patent and registered-design claims brought in the Patents Court under the Shorter Trials Scheme, or STS.
The cap is set at ยฃ500,000 for recoverable costs on the determination of liability, with a further ยฃ250,000 cap on any inquiry as to damages or account of profits. It runs as a three-year pilot on all patent claims issued in the STS. The scheme itself is fast and controlled: pleadings, disclosure and witness evidence are limited, a docketed judge manages the case, the trial is capped at four days including reading time, and judgment is targeted within around six weeks.
For a Leeds manufacturer or healthtech scale-up whose dispute is too valuable or too complex for the IPEC but who cannot stomach open-ended Patents Court costs, the STS is frequently the right answer. It only works, though, if the case is genuinely streamlined, and that is a judgement the infringement analysis has to make early. A claim that needs three experts and mountains of disclosure does not belong in a four-day trial, and we say so before it is issued.
UK patents after Brexit: there is no Unified Patent Court here
One jurisdictional fact governs every UK patent strategy, and it surprises people who follow European developments. The United Kingdom is not part of the Unified Patent Court. The UK signed the UPC Agreement but withdrew its ratification in July 2020, so the UPC and the unitary patent have no effect here at all.
What that means in practice is that a European patent designating the UK, once granted by the European Patent Office, takes effect as a national UK right and is enforced only in the UK courts, on the same footing as a patent granted directly by the UK Intellectual Property Office in Newport. There is no central European forum a Leeds patentee can use, and no risk of a single central revocation knocking out the UK part of the right. The UK stands alone, before its own judges.
For a Leeds company with a European portfolio, this splits enforcement in two. Continental infringement may be fought in the UPC or in national courts across Europe; the UK part is a separate action, decided under English law, on English claim-construction principles. An infringement analysis prepared for the UK cannot simply be lifted from a European opinion. The tests are not identical, and the differences decide cases.
What Leeds industries actually need analysed
Leeds has a distinctive economy, and it drives an unusually specific mix of infringement work. Health and digital health come first. Leeds is the national home of NHS England’s digital functions, the former NHS Digital, and hosts four of the five NHS national bodies, which has pulled a dense cluster of health-data and health-software companies into the city. Much of the patent analysis we do here concerns software-implemented inventions, data platforms and connected-health systems, where the hardest question is often what the claim actually covers.
Medical technology is close behind. The wider region carries a medtech cluster of more than 300 businesses employing over 16,000 people, from global names such as DePuy Synthes and Optum to homegrown firms like Aire Logic and PinPoint Data. Device patents bring their own analytical demands: claim charts against a physical product, cross-sections, and a hard look at the prior art in a crowded field. A thorough patent infringement analysis Leeds medtech companies commission usually runs infringement and validity in parallel, because the two are argued together.
Then there is fintech and financial services, a genuine Leeds strength, along with advanced manufacturing and engineering across West Yorkshire. Fintech throws up the recurring UK problem of excluded subject matter, where a method may be infringed on its face but the underlying patent is vulnerable on patentability. Manufacturing brings process and apparatus claims where the doctrine of equivalents does real work. Each sector needs the analysis pitched differently.
Typical Leeds instructions include:
- Infringement and validity opinions on health-software and data-platform patents
- Claim charts mapping an accused medical device against granted claims and the prior art
- Freedom-to-operate reviews before a Leeds product launch or funding round
- Subject-matter and validity checks on fintech and computer-implemented inventions
- Equivalents analysis on manufacturing process and apparatus claims
- Design-around opinions where the safer answer is to avoid the claim, not fight it
How we build an infringement analysis for a Leeds matter
Our method follows the same logic a UK court will, so that nothing in the opinion surprises you later. It runs through six disciplined steps, and the patent infringement analysis Leeds clients receive is built to survive cross-examination, not just to reassure.
First, we construe the claims. English law asks what the person skilled in the art would have understood the patentee to mean, reading the claims in the context of the specification. Construction is decided before infringement, and it usually decides infringement. We fix the meaning of every disputed term in writing before we look at the accused product.
Second, we map the construed claims onto the product or process, element by element, in a claim chart a judge can follow. Third, we consider equivalents. Since the Supreme Court’s decision in Actavis v Eli Lilly in 2017, a product outside the literal wording can still infringe if it varies the invention in an immaterial way, and that analysis has to be run explicitly rather than assumed.
Fourth, we test validity, because a defendant will almost always counterclaim for revocation, and an infringement win on an invalid patent is worthless. Fifth, we quantify: which court, what the sales support, whether the IPEC cap, the STS cap or the uncapped Patents Court fits. Sixth, we advise on threats, because the Intellectual Property (Unjustified Threats) Act 2017 makes an ill-judged warning letter actionable in itself. You can read the Unjustified Threats Act on legislation.gov.uk before any letter goes out. Only then do we recommend a route. The result is a document that tells you whether to litigate, settle, license or design around, on evidence, not instinct. This is where our Patent Infringement Analysis practice earns its place, and where a Leeds matter connects to prior art & litigation search, to patent invalidation when the better move is to attack a rival’s right, and to our United Kingdom IP hub.
IP Landscape & Resources in Leeds
Key intellectual-property authorities and venues relevant to Leeds:
- UK Intellectual Property Office (UKIPO) — the government body at Concept House, Newport that grants and administers UK patents and registered rights
- Business and Property Courts (Patents Court), judiciary.uk — the Chancery Division courts, including the Patents Court in the Rolls Building, that hear higher-value patent claims
- Intellectual Property Enterprise Court (IPEC), judiciary.uk — the proportionate forum for lower-value IP claims, with a ยฃ500,000 damages cap and capped recoverable costs
- Chancery Division regional centres, judiciary.uk — the Business and Property Courts District Registries, including Leeds on the North Eastern Circuit
Request a Patent Infringement Analysis Consultation in Leeds
Request a Patent Infringement Analysis Consultation in Leeds
Send us the patent, the accused product and any warning letter you have received. We will confirm scope, likely court and cost before any work begins, so a Leeds matter is assessed clearly before it ever reaches the Rolls Building.
Explore related PerspireIP services: Patent Infringement Analysis · patent invalidation · prior art & litigation search · our United Kingdom IP hub.
Frequently Asked Questions
Where is a Leeds company’s patent infringement claim actually heard?
In London. A patent infringement action in England and Wales can only be brought in the Patents Court or the Intellectual Property Enterprise Court, both housed in the Rolls Building in London. The UK Intellectual Property Office in Newport grants patents but does not hear infringement disputes, so a Leeds matter is prepared in West Yorkshire and litigated in London.
Can I bring a patent infringement claim in the Business and Property Courts in Leeds?
No. Although the Leeds District Registry has heard IPEC small claims track cases since 31 October 2019, patent and registered-design claims are expressly excluded from that track. Copyright, trade mark and unregistered design small claims can be run in Leeds, but a patent infringement claim must be issued in the Patents Court or the IPEC multi-track in London.
Should a Leeds SME use the Patents Court or the IPEC?
It depends on value and complexity. The IPEC caps damages at ยฃ500,000 and recoverable costs at ยฃ60,000 for liability and ยฃ30,000 for quantum, which makes cost exposure predictable for smaller businesses. The Patents Court is uncapped and suits larger, more complex disputes. We size the infringing sales and the technical complexity before recommending a forum.
Does the Shorter Trials Scheme help a mid-sized Leeds business?
Often, yes. Since 1 January 2024 a pilot caps recoverable costs at ยฃ500,000 on liability, and ยฃ250,000 on any quantum inquiry, for patent claims brought in the Patents Court under the Shorter Trials Scheme. It gives mid-tier Leeds companies a fast, cost-controlled route for disputes too big for the IPEC but not suited to open-ended Patents Court litigation.
Is a UK patent dispute heard by the Unified Patent Court?
No. The United Kingdom withdrew from the Unified Patent Court in July 2020, so neither the UPC nor the unitary patent has effect here. A European patent designating the UK is enforced as a national right in the UK courts only, under English law, entirely separately from any parallel action in the UPC or other European courts.
Why do Leeds healthtech and medtech companies need infringement analysis before litigating?
Because their patents are the hardest to enforce well. Software, data-platform and medical-device claims turn on precise construction and are frequently met with a validity counterclaim, so infringement and validity must be assessed together. Leeds is the home of NHS England’s digital functions and a large medtech cluster, and getting the analysis right decides whether litigation, licensing or a design-around is the sensible move.